Claudio Faria, PharmD, MPH

home / authors / claudio-faria-pharmd-mph

Articles

5-HT3 Receptor Antagonist Effects in Cancer Patients With Multiple Risk Factors

Claudio Faria, PharmD, MPH;Xuan Li, MS;Norman Nagl, PhD;Russell L. Knoth, PhD;Ali McBride, PharmD, MS

May 15th 2015

Palonosetron has been found to be effective in treating chemotherapy-induced nausea and vomiting, but no other studies that have compared it with the other 5-HT3 RAs are currently available.

Cost and Utilization Outcomes Associated With a Dosage Consolidation and Quantity Limits Program

Claudio Faria, PharmD, MPH;Christopher Ciano, RPh;Gary R. Tataronis, MS;Jake Nichols, PharmD, MBA;David Calabrese, RPh, MHP

October 27th 2010

Dose consolidation and quantity limit initiatives decreased utilization and cost outcomes for select mental health drugs in a fee-for-service Medicaid environment.

Published: October 23rd 2024 | Updated: October 24th 2024

What to Know About E Coli Outbreak Linked to McDonald’s Quarter Pounders